Vascular Parkinsonism Market

Future Market Insights

Vascular Parkinsonism Market

Key Insight

The vascular parkinsonism market is projected to grow from USD 319.5 million in 2025 to USD 538.1 million by 2035, at a robust CAGR of 6.20%. Dopaminergic agents will lead the drugs segment with 42.5% share, while oral administration will dominate the route of administration with 81.4% share.

July 02, 2025

Anurag Sharma

250 Pages

Cite this Report

Vascular Parkinsonism Market

https://www.futuremarketinsights.com/reports/vascular-parkinsonism-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

The Vanguard Group
BoehringerIngelheim
GlaxoSmithKline plc (GSK)
Novartis
Roche
L'Oréal
Sun Pharmaceutical Industries Ltd
Berkshire Hathaway

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Vascular Parkinsonism Market

Key Players

Similar Industry Reports